Table 2.
Characteristics of survey respondents (n = 1140)
| Characteristics of respondents | Geographical regions | Total % (n) |
|||||
|---|---|---|---|---|---|---|---|
| NA % (n/total) |
LA % (n/total) |
EU % (n/total) |
AME % (n/total) |
AP % (n/total) |
|||
| Specialtya (n = 1138) | |||||||
| Allergists/ Clinical Immunologists | 98.2 (324/330) | 97.4 (187/192) | 83.1 (315/379) | 79.7 (51/64) | 76.9 (133/173) | 88.7 (1010) | |
| Dermatologists | 0.3 (1/330) | 0.5 (1/192) | 9.8 (37/379) | 0 | 6.9 (12/173) | 4.5 (51) | |
| Pediatricians | 4.2 (14/330) | 25.5 (49/192) | 17.4 (66/379) | 23.4 (15/64) | 25.4 (44/173) | 16.5 (188) | |
| General Practitioners | 0.6 (2/330) | 3.1 (6/192) | 1.6 (6/379) | 6.2 (4/64) | 4 (7/173) | 2.2 (25) | |
| Gender (n = 1117) | |||||||
| Male | 58.5 (189/323) | 55.1 (102/185) | 43.7 (163/373) | 57.1 (36/63) | 58.4 (101/173) | 53.0 (591) | |
| Female | 41.5 (134/323) | 44.9 (83/185) | 56.3 (210/373) | 42.9 (27/63) | 41.6 (72/173) | 47.0 (526) | |
| Age, years (n = 1132) | |||||||
| < 40 | 22.9 (75/327) | 27.6 (53/192) | 28.2 (106/376) | 17.2 (11/64) | 23.1 (133/173) | 25.2 (285) | |
| ≥40 | 77.1 (252/327) | 72.4 (139/192) | 71.8 (270/376) | 82.8 (53/64) | 76.9 (133/173) | 74.8 (847) | |
| Clinical experience, years (n = 1130) | |||||||
| ≤19 | 50.3 (164/326) | 53.9 (104/193) | 58.2 (217/373) | 60.9 (39/64) | 63.2 (110/174) | 56.1 (634) | |
| Over 19 | 49.7 (162/326) | 46.1 (89/193) | 41.8 (156/373) | 39.1 (25/64) | 36.8 (64/174) | 43.9 (496) | |
| Place of worka (n = 1140) | |||||||
| Private practice | 63.9 (211/330) | 82.4 (159/193) | 34.6 (131/379) | 54.7 (35/64) | 46.0 (80/174) | 54.0 (616) | |
| University clinic | 70.3 (232/330) | 68.4 (132/193) | 57.5 (218/379) | 59.4 (38/64) | 71.8 (125/174) | 65.3 (745) | |
| Hospital | 11.8 (39/330) | 39.4 (76/193) | 43.3 (164/379) | 42.2 (27/64) | 58.6 (102/174) | 35.8 (408) | |
| Specialized urticaria centre | 0.9 (3/330) | 4.7 (9/193) | 2.9 (11/379) | 3.1 (2/64) | 0.3 (3/174) | 2.4 (28) | |
| Department (n = 1140) | |||||||
| Outpatients | 97.3 (321/330) | 89.6 (173/193) | 82.3 (312/379) | 81.3 (52/64) | 89.1 (155/174) | 88.9 (1013) | |
| Inpatients | 0.9 (3/330) | 8.8 (17/193) | 12.4 (47/379) | 10.9 (7/64) | 6.9 (12/174) | 7.5 (86) | |
| Outpatients and inpatients | 1.8 (6/330) | 1.6 (3/193) | 5.3 (20/379) | 7.8 (5/64) | 4.0 (7/174) | 3.6 (41) | |
| Age of patients (n = 1131) | |||||||
| Adults | 16.5 (54/327) | 17.2 (33/192) | 42.0 (158/376) | 10.9 (7/64) | 30.8 (53/172) | 27.0 (305) | |
| Children | 9.5 (31/327) | 16.7 (32/192) | 19.4 (73/376) | 18.8 (12/64) | 27.9 (71/172) | 19.3 (219) | |
| Adults and children | 74.0 (242/327) | 66.1 (127/192) | 38.6 (145/376) | 70.3 (45/64) | 41.3 (48/172) | 53.7 (607) | |
| Number of CSU patients per week (n = 1127) | |||||||
| < 10 | 75.5 (247/327) | 78.8 (152/193) | 80.7 (302/374) | 71.0 (44/62) | 78.4 (134/171) | 78.0 (879) | |
| ≥10 | 24.5 (80/327) | 21.2 (41/193) | 19.3 (72/374) | 29.0 (18/62) | 21.6 (37/171) | 22.0 (248) | |
| Patients with angioedema, % from the total number of CSU patients (n = 1131) | |||||||
| ≤20 | 37.7 (123/326) | 58.5 (113/193) | 51.7 (195/377) | 55.6 (35/63) | 66.3 (114/172) | 51.3 (580) | |
| > 20 | 62.3 (203/326) | 41.5 (80/193) | 48.3 (182/377) | 44.4 (28/63) | 33.7 (58/172) | 48.7 (551) | |
| Adherence to the urticaria guidelinesa (n = 1126) | |||||||
| Follow the guidelines | Any of three below | 88.0 (286/325) | 93.8 (180/192) | 97.3 (365/375) | 85.7 (54/63) | 89.5 (153/171) | 92.2 (1038) |
| EAACI/WAO/GA2LEN/EDF | 16.3 (53/325) | 78.1 (150/192) | 82.4 (309/375) | 68.3 (43/63) | 63.2 (108/171) | 58.9 (663) | |
| US practice parameters | 81.2 (264/325) | 32.3 (62/192) | 9.1 (34/375) | 28.6 (18/63) | 29.8 (51/171) | 38.1 (429) | |
| National | 7.1 (23/325) | 26.0 (50/192) | 32.5 (122/375) | 14.3 (9/63) | 30.4 (52/171) | 22.7 (256) | |
| Follow any but deviate | 40.0 (80/200) | 28.1 (25/89) | 49.4 (79/160) | 58.1 (18/31) | 53.8 (49/91) | 22.3 (251) | |
| Do not follow | 12.0 (39/325) | 6.3 (12/192) | 2.7 (10/375) | 14.3 (9/63) | 10.5 (18/171) | 7.8 (88) | |
AME Africa/Middle-East, AP Asia-Pacific, EU Europe, LA Latin America, NA North America. arespondents could choose more than one option